Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shalini Chaturvedi

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Biological Sciences|January 29, 2009
Assay validation for KIM-1: human urinary renal dysfunction biomarkerShalini Chaturvedi, Takeisha Farmer, Gordon F Kapke
The Journal of Biological Chemistry|May 15, 2007
Oleamide synthesizing activity from rat kidney: identification as cytochrome cWilliam J Driscoll, Shalini Chaturvedi, Gregory P Mueller
Haematologica|March 26, 2026
Predictive biomarkers of sustained treatment-free remission in chronic myeloid leukemia: gene expression analyses from the ENESTfreedom and ENESTop studiesJerald P Radich, Shalini Chaturvedi, Islam Sadek, et al.
International Journal of Biological Sciences|December 17, 2013
Development of a rapid streptavidin capture-based assay for the tyrosine phosphorylated CSF-1R in peripheral blood mononuclear cellsShalini Chaturvedi, Elayne Dell, Derick Siegel, et al.
Prostaglandins & Other Lipid Mediators|November 7, 2006
In vivo evidence that N-oleoylglycine acts independently of its conversion to oleamideShalini Chaturvedi, William J Driscoll, Brenda M Elliot, et al.
Cancer Treatment and Research Communications|November 14, 2020
Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib studyMichael Schaffer, Shalini Chaturvedi, Cuc Davis, et al.
Leukemia & Lymphoma|July 29, 2017
Identification of potential ibrutinib combinations in hematological malignancies using a combination high-throughput screenMichael Schaffer, Shalini Chaturvedi, Cuc Davis, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|September 8, 2007
Neural MMP-28 expression precedes myelination during development and peripheral nerve repairSean R Werner, Anthony L Mescher, Anton W Neff, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 21, 2025
Exploratory biomarker analysis from a phase III study of the PI3K inhibitor, copanlisib, in combination with rituximab in patients with indolent non-Hodgkin lymphoma, a retrospective studyShalini Chaturvedi, Anke Weispfenning, Tine Descamps, et al.
British Journal of Clinical Pharmacology|April 8, 2015
Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6Shalini Chaturvedi, Derick Siegel, Carrie L Wagner, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Biological Sciences|January 29, 2009
Assay validation for KIM-1: human urinary renal dysfunction biomarkerShalini Chaturvedi, Takeisha Farmer, Gordon F Kapke
The Journal of Biological Chemistry|May 15, 2007
Oleamide synthesizing activity from rat kidney: identification as cytochrome cWilliam J Driscoll, Shalini Chaturvedi, Gregory P Mueller
Haematologica|March 26, 2026
Predictive biomarkers of sustained treatment-free remission in chronic myeloid leukemia: gene expression analyses from the ENESTfreedom and ENESTop studiesJerald P Radich, Shalini Chaturvedi, Islam Sadek, et al.
International Journal of Biological Sciences|December 17, 2013
Development of a rapid streptavidin capture-based assay for the tyrosine phosphorylated CSF-1R in peripheral blood mononuclear cellsShalini Chaturvedi, Elayne Dell, Derick Siegel, et al.
Prostaglandins & Other Lipid Mediators|November 7, 2006
In vivo evidence that N-oleoylglycine acts independently of its conversion to oleamideShalini Chaturvedi, William J Driscoll, Brenda M Elliot, et al.
Cancer Treatment and Research Communications|November 14, 2020
Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib studyMichael Schaffer, Shalini Chaturvedi, Cuc Davis, et al.
Leukemia & Lymphoma|July 29, 2017
Identification of potential ibrutinib combinations in hematological malignancies using a combination high-throughput screenMichael Schaffer, Shalini Chaturvedi, Cuc Davis, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|September 8, 2007
Neural MMP-28 expression precedes myelination during development and peripheral nerve repairSean R Werner, Anthony L Mescher, Anton W Neff, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 21, 2025
Exploratory biomarker analysis from a phase III study of the PI3K inhibitor, copanlisib, in combination with rituximab in patients with indolent non-Hodgkin lymphoma, a retrospective studyShalini Chaturvedi, Anke Weispfenning, Tine Descamps, et al.
British Journal of Clinical Pharmacology|April 8, 2015
Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6Shalini Chaturvedi, Derick Siegel, Carrie L Wagner, et al.
Pageof 3